Discovery of novel allosteric GSK-3 inhibitors for the treatment of neurodegenerative diseases Sep. 22, 2014
Phase Ib data of synthetic cis-retinoid therapy for patients with genetic retinal defects Sep. 19, 2014
Autologous mesenchymal stem cell transplant evaluated in phase I multiple sclerosis trial Sep. 19, 2014